Article

Optos and Eyemaginations join operations

Optos announced a partnership with Eyemaginations Inc.

Marlborugh, MA-Optos announced a partnership with Eyemaginations Inc. The merger will allow both companies to deliver high-quality patient education materials to eye-care professionals.

"We are pleased to partner with Eyemaginations as both companies are committed to educating patients about eye health and overall systemic health," said Tom Daniells, vice president, marketing. "Eyemaginations' creative animation expertise will help us further illustrate important information to patients about the health of their retina and management of eye disease."

Eyemaginations has incorporated Optos' latest version of its proprietary software (V2 Vantage), which will offer educational animations as quick links to all current and new Optos partners as part of its software program.

The animations will help practitioners show patients about eye conditions such as diabetic retinopathy, retinal detachments, glaucoma, and choroidal nevi, which will help patients understand the importance of protecting their retinal health.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.